Skip to main content

Main menu

  • HOME
  • ONLINE FIRST
  • CURRENT ISSUE
  • ALL ISSUES
  • AUTHORS & REVIEWERS
  • SUBSCRIBE
  • BJGP LIFE
  • MORE
    • About BJGP
    • Conference
    • Advertising
    • eLetters
    • Alerts
    • Video
    • Audio
    • Librarian information
    • Resilience
    • COVID-19 Clinical Solutions
  • RCGP
    • BJGP for RCGP members
    • BJGP Open
    • RCGP eLearning
    • InnovAIT Journal
    • Jobs and careers

User menu

  • Subscriptions
  • Alerts
  • Log in

Search

  • Advanced search
British Journal of General Practice
Intended for Healthcare Professionals
  • RCGP
    • BJGP for RCGP members
    • BJGP Open
    • RCGP eLearning
    • InnovAIT Journal
    • Jobs and careers
  • Subscriptions
  • Alerts
  • Log in
  • Follow bjgp on Twitter
  • Visit bjgp on Facebook
  • Blog
  • Listen to BJGP podcast
  • Subscribe BJGP on YouTube
Intended for Healthcare Professionals
British Journal of General Practice

Advanced Search

  • HOME
  • ONLINE FIRST
  • CURRENT ISSUE
  • ALL ISSUES
  • AUTHORS & REVIEWERS
  • SUBSCRIBE
  • BJGP LIFE
  • MORE
    • About BJGP
    • Conference
    • Advertising
    • eLetters
    • Alerts
    • Video
    • Audio
    • Librarian information
    • Resilience
    • COVID-19 Clinical Solutions
Research

Cost-effectiveness of point-of-care C-reactive protein testing to inform antibiotic prescribing decisions

Raymond Oppong, Mark Jit, Richard D Smith, Christopher C Butler, Hasse Melbye, Sigvard Mölstad and Joanna Coast
British Journal of General Practice 2013; 63 (612): e465-e471. DOI: https://doi.org/10.3399/bjgp13X669185
Raymond Oppong
Roles: Research fellow in health economics;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark Jit
Roles: Mathematical modeller and health economist
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard D Smith
Roles: Professor of health system economics
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher C Butler
Roles: Professor of primary care medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hasse Melbye
Roles: Professor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sigvard Mölstad
Roles: Professor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joanna Coast
Roles: Professor of health economics
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info
  • eLetters
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1

    Incremental net benefits (INB) of CRP versus no CRP (95% CI).

  • Figure 2
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2

    Cost-effectiveness acceptability curve. CRP = C-reactive protein.

Tables

  • Figures
    • View popup
    Table 1

    Number of LRTI consultations where CRP tests are administered, by country

    CRP test n (%)No CRP test n (%)Total N (%)
    Sweden143 (64.4)79 (35.6)222 (100)
    Norway138 (93.2)10 (6.8)148 (100)
    All countries281 (76.0)89 (24.1)370 (100)
    • CRP = C-reactive protein. LRTI = lower respiratory tract infection.

    • View popup
    Table 2

    Patient characteristics at first clinic visit

    CRP test administered, mean (SD)No CRP test administered, mean (SD)P-value
    Age, years51.73 (15.14)52.30 (14.37)0.75
    Days of illness before consultation10.25 (8.41)11.04 (9.35)0.45
    EQ-5D at baseline0.669 (0.19)0.691 (0.20)0.37
    Severity score at baseline41.77 (16.22)39.08 (16.82)0.19
    Comorbidity0.32 (0.53)0.15 (0.39)<0.01
    Chest findings
      Diminished breath sounds0.09 (0.02)0.07 (0.03)0.36
      Wheeze0.21 (0.02)0.09 (0.03)0.01
      Crackles0.19 (0.02)0.15 (0.04)0.40
      Rhonchi0.18 (0.02)0.12 (0.04)0.20
    • CRP = C-reactive protein. SD = standard deviation.

    • View popup
    Table 3

    Relationship between administration of CRP test patient outcomes and resource use

    Without adjustment for cofactorsWith adjustment for cofactors
    Coefficient95% CIP-valueCoefficient95% CIP-value
    Antibiotic prescribinga−0.01−0.13 to 0.110.87−0.10−0.20 to 0.010.08
    Costs, €11.26−1.87 to 24.410.0911.27−1.86 to 24.410.09
    Severity day 7a−0.38−4.15 to 3.390.84−0.20−3.77 to 3.370.91
    Severity day 14a0.97−2.44 to 4.380.581.34−2.23 to 4.910.46
    EQ-5D week 10.02−0.03 to 0.070.480.02−0.28 to 0.070.43
    EQ-5D week 20.04−0.01 to 0.080.090.03−0.02 to 0.070.24
    Days to recoverya0.07−2.04 to 2.180.950.50−1.62 to 2.620.65
    QALY gain0.002−0.001 to 0.0040.260.0012−0.001 to 0.0040.35
    Day patient felt wella−0.42−2.57 to 1.720.70−0.95−3.21 to 1.310.41
    GP visits0.10−0.06 to 0.260.220.13−0.05 to 0.300.15
    Hospital admissions−0.02−0.04 to −0.010.01−0.02−0.04 to −0.0020.03
    Medical investigations1.271.10 to 1.45<0.011.281.10 to 1.47<0.01
    Nurse visits0.01−0.05 to 0.070.790.02−0.05 to 0.090.63
    Specialist visits0.01−0.01 to 0.020.420.01−0.01 to 0.030.42
    Out of hours GP−0.02−0.05 to 0.020.37−0.03−0.07 to 0.010.12
    • ↵a A negative coefficient indicates a positive result. CRP = C-reactive protein. QALY = quality-adjusted life years.

Back to top
Previous ArticleNext Article

In this issue

British Journal of General Practice: 63 (612)
British Journal of General Practice
Vol. 63, Issue 612
July 2013
  • Table of Contents
  • Index by author
Download PDF
Download PowerPoint
Article Alerts
Or,
sign in or create an account with your email address
Email Article

Thank you for recommending British Journal of General Practice.

NOTE: We only request your email address so that the person to whom you are recommending the page knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Cost-effectiveness of point-of-care C-reactive protein testing to inform antibiotic prescribing decisions
(Your Name) has forwarded a page to you from British Journal of General Practice
(Your Name) thought you would like to see this page from British Journal of General Practice.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Cost-effectiveness of point-of-care C-reactive protein testing to inform antibiotic prescribing decisions
Raymond Oppong, Mark Jit, Richard D Smith, Christopher C Butler, Hasse Melbye, Sigvard Mölstad, Joanna Coast
British Journal of General Practice 2013; 63 (612): e465-e471. DOI: 10.3399/bjgp13X669185

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Cost-effectiveness of point-of-care C-reactive protein testing to inform antibiotic prescribing decisions
Raymond Oppong, Mark Jit, Richard D Smith, Christopher C Butler, Hasse Melbye, Sigvard Mölstad, Joanna Coast
British Journal of General Practice 2013; 63 (612): e465-e471. DOI: 10.3399/bjgp13X669185
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
  • Mendeley logo Mendeley

Jump to section

  • Top
  • Article
    • Abstract
    • INTRODUCTION
    • METHOD
    • RESULTS
    • DISCUSSION
    • Acknowledgments
    • Notes
    • REFERENCES
  • Figures & Data
  • Info
  • eLetters
  • PDF

Keywords

  • antibiotics
  • cost-effectiveness
  • C-reactive protein
  • primary health care
  • respiratory tract infections

More in this TOC Section

  • Advance care planning in primary care for patients with gastrointestinal cancer: feasibility randomised trial
  • Diagnoses after newly recorded abdominal pain in primary care: observational cohort study
  • Early implementation of the structured medication review in England: a qualitative study
Show more Research

Related Articles

Cited By...

Intended for Healthcare Professionals

BJGP Life

BJGP Open

 

@BJGPjournal's Likes on Twitter

 
 

British Journal of General Practice

NAVIGATE

  • Home
  • Current Issue
  • All Issues
  • Online First
  • Authors & reviewers

RCGP

  • BJGP for RCGP members
  • BJGP Open
  • RCGP eLearning
  • InnovAiT Journal
  • Jobs and careers

MY ACCOUNT

  • RCGP members' login
  • Subscriber login
  • Activate subscription
  • Terms and conditions

NEWS AND UPDATES

  • About BJGP
  • Alerts
  • RSS feeds
  • Facebook
  • Twitter

AUTHORS & REVIEWERS

  • Submit an article
  • Writing for BJGP: research
  • Writing for BJGP: other sections
  • BJGP editorial process & policies
  • BJGP ethical guidelines
  • Peer review for BJGP

CUSTOMER SERVICES

  • Advertising
  • Contact subscription agent
  • Copyright
  • Librarian information

CONTRIBUTE

  • BJGP Life
  • eLetters
  • Feedback

CONTACT US

BJGP Journal Office
RCGP
30 Euston Square
London NW1 2FB
Tel: +44 (0)20 3188 7400
Email: journal@rcgp.org.uk

British Journal of General Practice is an editorially-independent publication of the Royal College of General Practitioners
© 2022 British Journal of General Practice

Print ISSN: 0960-1643
Online ISSN: 1478-5242